Inki Lee, J. Paeng, Soo Jin Lee
Aug 26, 2015
Citations
1
Influential Citations
26
Citations
Quality indicators
Journal
Nuclear Medicine and Molecular Imaging
Abstract
PurposeIn-pentetreotide has been used for neuroendocrine tumors expressing somatostatin receptors. Recently, 68Ga-DOTATOC PET has been used with the advantage of high image quality. In this study, we compared quantitative indices between 111In-pentetreotide SPECT/CT and 68Ga-DOTATOC PET/CT.MethodsThirteen patients diagnosed with neuroendocrine tumors were prospectively recruited. Patients underwent 111In-pentetreotide scans with SPECT/CT and 68Ga-DOTATOC PET/CT before treatment. The number and location of lesions were analyzed on both imaging techniques to compare lesion detectability. Additionally, the maximal uptake count of each lesion and mean uptake count of the lungs were measured on both imagings, and target-to-normal lung ratios (TNR) were calculated as quantitative indices.ResultsAmong 13 patients, 10 exhibited lesions with increased uptake on 111In-pentetreotide SPECT/CT and/or 68Ga-DOTATOC PET/CT. Scans with SPECT/CT detected 19 lesions, all of which were also detected on PET/CT. Moreover, 16 additional lesions were detected on PET/CT (6 in the liver, 9 in the pancreas and 1 in the spleen). PET/CT exhibited a significantly higher sensitivity than SPECT/CT (100 % vs. 54 %, P < 0.001). TNR was significantly higher on PET/CT than on SPECT/CT (99.9 ± 84.3 vs. 71.1 ± 114.9, P < 0.001) in spite of a significant correlation (r = 0.692, P = 0.01).ConclusionGa-DOTATOC PET/CT has a higher diagnostic sensitivity than 111In-pentetreotide scans with SPECT/CT. The TNR on PET/CT is higher than that of SPECT/CT, which also suggests the higher sensitivity of PET/CT. 111In-pentetreotide SPECT/CT should be used carefully if it is used instead of 68Ga-DOTATOC PET/CT.